Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of May 2025. The report specifically details a transaction in the company's own shares executed under its share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
| Metric | Value |
|---|---|
| Date of Purchase | May 07, 2025 |
| Shares Purchased | 828,853 |
| Highest Price Paid | 402.30 pence |
| Lowest Price Paid | 396.20 pence |
| Volume Weighted Average Price | 400.17 pence |
| Registered Share Capital | 9,018,385,319 ordinary shares |
| Treasury Shares Held | 4,080,205 |
| Voting Shares Outstanding | 9,014,305,114 |
Material Changes
Following the settlement of the repurchase, the number of ordinary shares with voting rights decreased to 9,014,305,114. The filing notes that this figure is the basis for shareholders to determine notification requirements under the FCA's Disclosure Guidance and Transparency Rules.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It is a routine disclosure of a capital return transaction.
Key Facts for Investor Verification
- Verify the total number of shares repurchased to date under the March 28, 2025 Buyback Programme.
- Confirm the current market price of Haleon shares relative to the 400.17 pence average purchase price.
- Review the full trade breakdown available via the London Stock Exchange link provided in the filing for granular transaction data.
- Monitor future filings for updates on the remaining capacity of the share buyback programme.